País: Estados Unidos
Idioma: inglés
Fuente: NLM (National Library of Medicine)
LACTIC ACID, L- (UNII: F9S9FFU82N) (LACTIC ACID, L- - UNII:F9S9FFU82N)
Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LACTIC ACID, L-
LACTIC ACID, L- 2 [hp_X]
ORAL
OTC DRUG
Flu, Muscular Prostration Condition listed above or as directed by the physician
unapproved homeopathic
SARCOLACTICUM ACIDUM- SARCOLACTICUM ACIDUM PELLET RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for_ _safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective._ ---------- ACTIVE INGREDIENT SARCOLACTICUM ACIDUM HPUS 2X and higher USES Flu, Muscular Prostration INDICATIONS Condition listed above or as directed by the physician DOSAGE Adults- Take 4 or 6 Pellets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose. WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are preganant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use. INACTIVE INGREDIENTS Sucrose STORAGE Store in a cool dark place QUESTIONS OR COMMENTS www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com Rxhomeo, Inc 9415 Burnet Road, Suite 312, Austin, TX 78758 SARCOLACTICUM ACIDUM sarcolacticum acidum pellet PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:156 31-0 39 2 ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH LACTIC ACID, L- (UNII: F9 S9 FFU8 2N) (LACTIC ACID, L- - UNII:F9 S9 FFU8 2N) LACTIC ACID, L- 2 [hp_X] INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH SUCRO SE (UNII: C151H8 M554) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:156 31-0 39 2- 0 10 0 in 1 VIAL, SINGLE-DOSE; Type 0 : No t a Co mbinatio n Pro duc t 0 1/0 1/20 18 2 NDC:156 31-0 39 2- 1 20 0 in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct 0 1/0 1/20 18 3 NDC:156 31-0 39 2- 2 40 0 in 1 PACKAGE; Type 0 : No t a Co mbinatio n Pro duct 0 1/0 1/20 18 4 NDC:156 31-0 39 2- 3 750 in Leer el documento completo